4-N-苯胺基喹啉衍生物的合成及胆碱酯酶抑制活性

设计合成了一系列4-N-苯胺基喹啉类衍生物,采用Ellman法测定了目标化合物对乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)的抑制活性.结果表明,当喹啉环上连有伸长的吡啶季铵盐片段时,可显著提高目标化合物的胆碱酯酶抑制作用.化合物16对AChE和BChE具有明显的双重抑制作用,其IC_(50)值分别为0.92和14.20μmol/L,抑制效果强于阳性对照药加兰他敏.     

呋喃并呫吨酮衍生物的合成与生物活性研究

以水杨酸、间苯三酚为原料合成了1,3-二羟基呫吨酮, 经醚化、环化反应得到1-羟基呋喃并呫吨酮3a和3b, 再经Mannich反应合成了10个呋喃并呫吨酮衍生物4和5, 接着通过季铵化反应得到相应的10个季铵盐6和7. 运用IR、一维和二维NMR、MS、元素分析等对化合物进行了结构表征, 考察了化合物4～7对乙酰胆碱酯酶的抑制作用及化合物6, 7的抗癌活性. 结果表明: 化合物4～7对乙酰胆碱酯酶具有较好的抑制活性, IC50＝2.0～12.4 μmol/L; 化合物6, 7对肝癌(HepG2)、肺癌(SPC-A)、口腔上皮癌(KB)、乳腺癌(MCF-7)这四种癌细胞株的增殖均有抑制作用, 其中化合物6c对癌细胞株HepG2、化合物7d对癌细胞株MCF-7的抑制作用最强, IC50分别为0.82和0.77 μmol/L.     

含哌嗪酰胺类杨梅素衍生物的合成及生物活性

以杨梅苷、哌嗪和各种芳香酸为原料,通过甲基化保护羟基和脱苷形成选择性单一的杨梅素中间体,然后以三步取代反应连接哌嗪和芳香酸,合成了13个新型含哌嗪酰胺类杨梅素衍生物.采用四甲基偶氮唑盐(MTT)比色法测试了化合物对人类乳腺癌细胞(MDA-MB-231)体外增殖的抑制活性.结果表明,大多数含哌嗪酰胺的杨梅素衍生物对MDA-MB-231细胞表现出较好的抑制活性.当浓度为1μmol/L时,化合物4a和4i的抑制活性均高于阳性对照药盐酸表阿霉素;当浓度为10μmol/L时,化合物4h和4i的抑制活性高达86.7%和83.6%.     

1,2-苯并噻嗪类化合物的设计、合成及抗肿瘤活性研究

依据生物电子等排原理,设计合成了13个全新结构的1,2-苯并噻嗪类化合物,其结构均经IR,1H NMR,13C NMR和MS确证.以A431,A549,MDA-MB-468和HL60 4种细胞株为活性筛选对象,采用四甲基偶氮唑盐(MTT)法进行初步的体外抗肿瘤活性研究.结果表明,部分化合物对肿瘤细胞有一定的抑制活性,其中化合物5b对A431具有显著的抑制活性,IC50值为1.57μmol/L,化合物9a对A431,A549和MDA-MB-468 3种细胞株的抑制活性均强于阳性对照药gefitinib.并采用Moe软件对所合成的化合物与表皮生长因子受体(EGFR)结合位点进行对接,以进一步阐释所合成化合物的作用靶标.     

白藜芦醇衍生物的合成及抑制宫颈癌HeLa细胞肿瘤活性

以白藜芦醇、氯乙酰氯、对甲苯磺酰氯、对甲苯甲酰氯为原料,合成9种新的白藜芦醇衍生物,其结构经IR,1HNMR,13C NMR和HRMS所表征.用3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(MTT)法测试了目标化合物抑制宫颈癌HeLa细胞的肿瘤活性,结果表明:化合物4a,6a,7b,8b和11c对HeLa细胞的抑制活性比白藜芦醇高,其中化合物6a和8b的抑制效果最明显,其IC50值分别为22.7和18.0μmol/L,活性高于白藜芦醇(IC50=114μmol/L),且在150μmol/L浓度下对HeLa细胞的抑制率达95.5%和87.7%.     

胡椒碱-双环酰胺衍生物的设计、合成及抗宫颈癌活性

以胡椒碱为母核进行结构改造,合成了一系列胡椒碱-双环酰胺衍生物;并用核磁共振氢谱(1H NMR),核磁共振碳谱(13C NMR)和高分辨质谱(HRMS)进行了结构确证.噻唑蓝(MTT)比色法测试结果表明,目标化合物对肾细胞(293T)、宫颈癌(HeLa)和乳腺癌(MDA-MB-321)细胞有良好的抑制活性,大多数衍生物对HeLa细胞的抑制活性优于阳性对照药5-氟尿嘧啶(5-FU)和胡椒碱.化合物6b对HeLa细胞的抗增殖活性最高,半数抑制浓度(IC50)为3.49μmol/L,对MDA-MB-321细胞的IC50值为20.89μmol/L.机理研究发现,化合物6b不仅可有效抑制HeLa细胞的迁移、侵袭、黏附和克隆能力,而且对HeLa细胞肿瘤异种移植物的生长表现出强烈的抑制作用.因此,化合物6b有可能成为肿瘤治疗中潜在的先导化合物.     

新型香豆素类衍生物的合成及抗肿瘤活性研究

为了寻找结构新颖、活性较好的抗肿瘤化合物,设计合成了19个未见文献报道的3,4,5-三甲氧基苯基香豆素类化合物,并用核磁共振(NMR)和高分辨质谱(HRMS)等方法对化合物结构进行表征.用四甲基偶氮唑盐(MTT)法评价了该类化合物对人前列腺癌细胞(PC-3)、人食管癌细胞(EC-109)和人胃癌细胞(MGC-803)三种肿瘤细胞的抑制活性.结果显示,N-苄基-2-((4-甲基-2H-色烯-2-酮-7-基)氧基)-N-(3,4,5-三甲氧基苯基)乙酰胺(4a)和N-((5-氯苯并[b]噻吩-3-基)甲基)-2-((4-甲基-2H-色烯-2-酮-7-基)氧基)-N-(3,4,5-三甲氧基苯基)乙酰胺(4n)对三种肿瘤细胞的抑制活性优于阳性对照药5-氟尿嘧啶,其中化合物4n对人前列腺癌细胞(PC-3)的抑制活性最好,其IC_(50)为4.18μmol/L.     

丁苯酞-哒嗪酮衍生物的设计、合成及其抗凝活性研究

为了提高丁苯酞的抗血小板凝集活性,以6-氨基丁苯酞为起始原料,经重氮化/还原、环化、水解、脱氯、醚化和磺酰化反应合成了20个新型的丁苯酞-哒嗪酮衍生物,其结构经1H-NMR、13C-NMR和HRMS确证。体外抗血小板凝集活性测试结果表明:化合物6a、6b和6k对二磷酸腺苷(ADP)诱导的血小板凝集的抑制活性(IC50 = 44.9-180.0 μmol/L)优于先导化合物丁苯酞(IC50 = 1252 μmol/L)和阳性对照阿司匹林(IC50 = 1140 μmol/L);同时化合物 6b(IC50 = 63.6 μmol/L)和6k(IC50 = 191.9 μmol/L)对花生四烯酸(AA)诱导的血小板凝集也表现出显著的抑制活性。本研究为丁苯酞-哒嗪酮骨架在治疗缺血性脑卒中方面的研究提供了理论参考。     

水杨酰氧基膦酸酯衍生物的微波辅助合成及抗肿瘤活性研究

微波辅助下,采用水杨酸与α-羟基膦酸酯在DCC/DMAP催化下酯化,合成了12个结构新颖的水杨酰氧基膦酸酯衍生物,其结构经IR,1H NMR,13C NMR及元素分析确认.优化得最适微波合成条件:以15 m L CH2Cl2为溶剂,辐射功率800 W,室温反应3.5 h,有最好产率,该方法具有反应时间较短、产率较高等优点.四甲基偶氮唑蓝(MTT)法测试了目标化合物的抗肿瘤活性,结果表明:目标化合物对所测试的四种肿瘤细胞均有增殖抑制作用.其中化合物2f对HEp-2的抑制活性[IC50=(13.9±0.6)μmol/L]略低于对照药[IC50=(9.3±1.1)μmol/L],化合物2k对EC-109的抑制活性[IC50=(8.5±0.9)μmol/L]接近对照药[IC50=(5.9±1.0)μmol/L].     

双-β-咔啉衍生物的设计、合成及抗肿瘤活性

以去氢骆驼蓬碱为原料, 经过脱甲基、 烷基化等步骤, 合成了一系列双-β-咔啉衍生物. 目标化合物均经核磁共振谱(NMR)和质谱(MS)进行结构确证. 以顺铂为阳性对照药, 采用四甲基偶氮唑盐(MTT)法考察了目标化合物体外抗肿瘤(Bel-7402, 786-0, BGC-823, A375, 769-P和MCF7等6株细胞)活性. 结果表明, 化合物4g和4o与阳性对照药相比具有良好的抗肿瘤活性, 其半抑制浓度(IC₅₀)值均小于10 μmol/L. 初步构效关系研究表明, 当桥链亚甲基数目为8~10, β-咔啉环上9-丁基或9-异丁基取代时, 化合物的抗肿瘤活性较强.     

A phosphorimetric investigation of the external heavy-atom effect in aqueous solution and its correlation with phosphorescence intensity and quantum yield

Excitation and emission phosphorescence spectra, lifetimes, and relative quantum yields of benzene and ten monosubstituted benzenes were determined at 77 K in methanol/water 10/90 v/v and in sodium iodide/methanol/water solutions. Substituents CHO, COCH(3), COC(2)H(5), OH, OCH(3), H(3), C(2)H(5), CH(2)OH and N(CH(3))(2) were investigated. Aqueous sodium iodide solutions were found to be a suitable heavy-atom solvent for phosophorimetry. Heavy-atom enhancement factors ranged from 1.2 to 8.3 according to the molecular structure and a marked decrease of the lifetime was observed for nine compounds in aqueous sodium iodide solution. A linear log-log correlation was obtained between the relative corrected phosphorescence signal and the heavy-atom enhancement factor of the monosubstituted benzenes. A similar correlation was found between the quantum yields and the heavy-atom enhancement factors. The analytical usefulness of these correlations is evident for the prediction of the magnitude of the heavy-atom effect.     

The first 1-alkyl-3-perfluoroalkyl-4,5- dimethyl-1,2,4-triazolium salts

Syntheses of quaternary 1-alkyl-3-perfluoroalkyl-4,5-dimethyl-1,2,4-triazolium iodides have led to a variety of new quaternary salts via metathesis reactions. 1,4,5-Trimethyl-3-trifluoro-methyl-1,2,4-triazolium iodide (6) with LiN(SO(2)CF(3))(2), KSO(3)CF(3), AgClO(4), AgBF(4); 1-(3-fluoropropyl)-3-trifluoromethyl-4,5-dimethyl-1,2,4-triazolium iodide (7) with LiN(SO(2)CF(3))(2); and 1,4,5-trimethyl-3-perfluorooctyl-1,2,4-triazolium iodide (8) with LiN(SO(2)CF(3))(2), AgClO(4), AgBF(4) gave excellent yields of new thermally stable and relatively low melting quaternary salts. The structure of 1,4,5-trimethyl-3-perfluorooctyl-1,2,4-triazolium tetrafluoroborate (11c) was confirmed by single-crystal X-ray analysis. Although the molecular weight of 11c (cation) is 3-fold greater than that of the 3-trifluoromethyl derivative 9d, its melting point is 32 degrees C lower.     

Rapid and direct determination of iodide in seawater by electrostatic ion chromatography

An electrostatic ion chromatographic (IC) method for rapid and direct determination of iodide in seawater is reported. Separation was achieved using a reversed-phase ODS packed column (250x4.6 mm I.D.) modified by coating with Zwittergent-3-14 micelles, with an eluent comprising an aqueous solution containing 0.2 mM NaClO4 and 0.3 mM Zwittergent-3-14 and using UV detection at 210 nm. Samples prepared by dissolving NaIO3, NaNO2, NaBr, NaBrO3, NaNO3, NaI, and NaSCN in artificial or real seawaters were analyzed using this IC system. Nitrite, iodate, bromide, bromate, and nitrate showed very little or no retention, while iodide and thiocyanate were well separated, being eluted within 6 and 16 min, respectively. The detection limit for iodide obtained by injecting 400 microL of sample was 0.011 microM (S/N = 3), and the precision values obtained by analyzing samples containing 0.1 or 0.3 microM iodide in real seawater samples were 2.3% RSD and 1.2% RSD, respectively. Direct determination of iodide in real seawater samples was possible using this proposed IC system.     

Inhibition kinetic determination of trace amount of iodide by the spectrophotometric method with rhodamine B

Trace iodide was determined by inhibition kinetic method, which based on its inhibition effects on the reaction between rhodamine B (RhB) and KBrO(3) in H(2)SO(4) medium in 45+/-0.5 degrees C for 15 min. The signal difference (DeltaA, DeltaF) between inhibited reaction and non-inhibited reaction is linear with the concentration of iodide. The linear range were 2.0-6.0 and 1.0-6.0 ng mL(-1) and the detection limit were 0.06 and 0.07 ng mL(-1), respectively. The method has been applied satisfactorily to the determination of iodide in kelp.     

Influence of ion pairing on the oxidation of iodide by MLCT excited states

The oxidation of iodide to diiodide, I(2)˙(-), by the metal-to-ligand charge-transfer (MLCT) excited state of [Ru(deeb)(3)](2+), where deeb is 4,4'-(CO(2)CH(2)CH(3))(2)-2,2'-bipyridine, was quantified in acetonitrile and dichloromethane solution at room temperature. The redox and excited state properties of [Ru(deeb)(3)](2+) were similar in the two solvents; however, the mechanisms for excited state quenching by iodide were found to differ significantly. In acetonitrile, reaction of [Ru(deeb)(3)](2+*) and iodide was dynamic (lifetime quenching) with kinetics that followed the Stern-Volmer model (K(D) = 1.0 ± 0.01 × 10(5) M(-1), k(q) = 4.8 × 10(10) M(-1) s(-1)). Excited state reactivity was observed to be the result of reductive quenching that yielded the reduced ruthenium compound, [Ru(deeb(-))(deeb)(2)](+), and the iodine atom, I˙. In dichloromethane, excited state quenching was primarily static (photoluminescence amplitude quenching) and [Ru(deeb(-))(deeb)(2)](+) formed within 10 ns, consistent with the formation of ion pairs in the ground state that react rapidly upon visible light absorption. In both solvents the appearance of I(2)˙(-) could be time resolved. In acetonitrile, the rate constant for I(2)˙(-) growth, 2.2 ± 0.2 × 10(10) M(-1) s(-1), was found to be about a factor of two slower than the formation of [Ru(deeb(-))(deeb)(2)](+), indicating it was a secondary photoproduct. The delayed appearance of I(2)˙(-) was attributed to the reaction of iodine atoms with iodide. In dichloromethane, the growth of I(2)˙(-), 1.3 ± 0.4 × 10(10) M(-1) s(-1), was similar to that in acetonitrile, yet resulted from iodine atoms formed within the laser pulse. These results are discussed within the context of solar energy conversion by dye-sensitized solar cells and storage via chemical bond formation.     

Kinetic determination of iodide in pharmaceutical and food samples

A kinetic method for the determination of iodide based on its inhibitory effect on the Pd(III) catalysed reaction between ethylenediaminetetraacetic acid (EDTA)-Co(III) and the hypophosphite ion is described. The reaction was followed spectrophotometrically by measuring the decrease in the absorbance at 540 nm. Under the optimum experimental conditions of 2.6 x 10(-3) mol dm(-3)Co(III)-EDTA, 0.4 mol dm(-3)H2PO2-, pH 3.2 (adjusted with Britton-Robinson buffer), 0.57 micrograms ml(-1) Pd(III) and 20 +/- 0.2 degrees C, iodide was determined in the range 2-28 ng ml(-1). The method was applied to the determination of iodide in pharmaceutical products, iodinated salts, cow's milk and infants' powdered milk.     

Selective recognition iodide in aqueous solution based on fluorescence enhancement chemosensor

A novel and simple fluorescence enhancement method for selectively sensing iodide was proposed based on metal complex formation between mercuric(II) ion with fluorophore (p-((dimethylamino)benzylidene)thiosemicarbazide, 1) and with anion in aqueous solution. The 1-Hg complex was found to show selectively and sensitively fluorescence enhancement response toward iodide over than S(2-), EDTA, SCN-, CH(3)CO(2-), Br-, Cl-, F-, H2PO4- and SO4(2-), which was attributed to the higher stability of inorganic complex between iodide and mercuric(II).     

Sensitive flow-injection amperometric detection of iodide using Mn3+ and As3+.

A rapid, selective, and sensitive kinetic flow-injection method for iodide content determination with amperometric detection on a platinum electrode was developed. The method is based on the catalytic effect of iodide on the Mn3+ reaction with As3+ in the presence of sulfuric acid. The calibration curve was linear in the concentration range from 5.0 x 10(-7) to 1.0 x 10(-4) mol/L iodide. The limit of detection (LOD) was found to be 5.0 x 10(-9) mol/L iodide. The relative standard deviations (RSD) were 1.68% and 3.03% for 1.0 x 10(-3) mol/L standard and 1.0 x 10(-6) mol/L iodide solution (n = 6), respectively. The method has been successfully applied for determination of iodide in waters, table salts, fodder, organic substances and human blood sera. The results were compared with those obtained by a standard AOAC (Association of Official Analytical Chemists) method, as well as with those obtained by a kinetic spectrophotometric procedure for determination of iodide.     

Synthesis and cytotoxicity of 28-carboxymethoxy lupane triterpenoids. Preference of 28-O-acylation over 28-O-alkylation of betulin by ethyl bromoacetate

28-Carboxymethoxy lupane tritepenoids 3 and 4 were synthesized by alkylation of betulin with the THP protected 2-hydroxyethyl iodide followed by oxidation and reduction.Direct reaction of betulin (5) or betulone (10) with ethyl bromoacetate led to 28-O-acylation, instead of 28-O-alkylation.The targeted compounds 3 and 4 were not cytotoxic at the highest concentrationtested (75 mmol/L), suggesting that elongation of the chain length at the 28-position in both betulinic acid (1) and betulonic acid (2)was detrimental to the cytotoxicity.The acylation products 28-O-bromoacetates (8a, 8b and 11) and 28-O-methoxyacetate 13exhibited cytotoxicity against several cancer cell lines tested.     

Syntheses and Crystal Structures of New Palladium(II) and Platinum(IV) Trialkylsulfonium Compounds

The reactions of platinum(II) iodide with triethyl‐ or trimethylsulfonium iodide in acetonitrile solution lead to the formation of crystalline products (Et₃S)₂[PtI₆] ( 1 ) and [Me₃S]₂[PtI₆]·CH₃CN ( 2 ), respectively. The formation of Pt(IV) complexes may be explained either by disproportionation of PtI₂ or oxidation by oxygen. Palladium(II) iodide reacts with triethylsulfonium iodide to give the palladium(II) complex (Et₃S)₂[PdI₄] ( 3 ). The crystal structures of 1 – 3 were determined by single‐crystal X‐ray diffraction. In the crystal structures, the compounds 2 and 3 exhibit an extensive hydrogen‐bonding network.